Advanced Infusion Therapies Delivered with Safety, Expertise, and Care.

Cinqair® (Reslizumab) IV Infusion Therapy

Targeted Biologic Therapy for Severe Eosinophilic Asthma

Clearwell Infusion Centers offers safe, professional administration of Cinqair (reslizumab) for patients with severe eosinophilic asthma. As a trusted infusion center in Miami, we provide private suites, flexible scheduling, and personalized care in a calming, patient-first environment.

What Is Cinqair?

Cinqair® (reslizumab) is an FDA-approved biologic therapy used to treat severe eosinophilic asthma in adults. It works by targeting and blocking interleukin-5 (IL-5), a key inflammatory signal involved in the overproduction of eosinophils — a type of white blood cell that contributes to asthma symptoms and flare-ups.

Cinqair is administered as an intravenous (IV) infusion every 4 weeks and is used alongside your regular asthma maintenance treatments to reduce exacerbations and improve lung function.

Conditions Treated with Cinqair

Cinqair is approved for:

  • Severe eosinophilic asthma in adults

Cinqair is typically prescribed when other asthma medications are not enough to keep symptoms under control.

Cinqair Side Effects

As with any IV biologic therapy, side effects may occur.

Common side effects:

  • Throat pain
  • Muscle pain
  • Fatigue
  • Infusion-related reactions (fever, rash, itching, shortness of breath)
  • Rare but serious allergic reactions (anaphylaxis)

Our clinical team will monitor for any side effects and communicate with your referring provider to ensure a safe and effective treatment experience.

For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Cinqair Website.

Why Choose Clearwell for Your Cinqair Infusion?

Clearwell Infusion Centers is built for comfort, clinical safety, and convenience. When you receive Cinqair IV therapy at Clearwell, you benefit from:

  • Private treatment suites with spa-like amenities
  • Low patient-to-nurse ratio for attentive care
  • Flexible appointment times, including weekends and evenings
  • Comprehensive insurance coordination, including prior authorizations and benefits checks
  • ACHC-accredited facility and safety standards
  • Close coordination with your prescribing provider and care team

Cinqair infusions typically take 20 to 50 minutes and are administered once every 4 weeks.

Getting Started with Cinqair Treatment

If you have severe eosinophilic asthma and have been prescribed Cinqair, Clearwell can help you get started quickly and confidently. We’ll coordinate with your pulmonologist or allergist, handle insurance approvals, and schedule your treatment at your convenience.

Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

Clearwell Infusion Centers works closely with pulmonologists, allergists, and primary care providers to deliver Cinqair therapy in a high-quality, accredited setting.

Why refer your patients to Clearwell?

  • Fast turnaround for insurance approvals and benefit checks
  • Easy referral process and same-week scheduling
  • Clinical documentation and follow-up sent to your office
  • Trusted administration of FDA-approved biologics
  • ACHC-accredited and compliant with all safety protocols

To refer a patient for Cinqair infusion therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Cinqair® (reslizumab) injection product logo featuring the brand name and dosage information.

Looking to start your Cinqair treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you

← Back

Your message has been sent and a member of our team will contact you. You can call us at (305)306-7147